Medicine
Piperacillin and Tazobactam 2 g/250 mg per 50 mL injection
Piperacillin and Tazobactam 2 g/250 mg per 50 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage conditions for reconstituted Piperacillin and Tazobactam for Injection…
Key facts
- Active ingredient (INN)
- Piperacillin and Tazobactam
- Brand
- Sold under the generic name
- Strength
- 2 g/250 mg per 50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 containers of 50 mL
- Manufacturer
- B. Braun Medical
- Origin register
- US FDA, United States
- Storage
- Storage conditions for reconstituted Piperacillin and Tazobactam for Injection are described in another section of labeling.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 2025
- Identifiers
- RxCUI 1659131, 1659137, 1659149DailyMed set ID a63ca653-27d4-45fe-a744-77e0efe45220NDC 0264-3446Application NDA206056
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 container in 1 case / 50 mL in 1 container | 0264-3446-11 | B. Braun Medical | 30 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 October 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Piperacillin and Tazobactam 2 g/250 mg per 50 mL injection.
Other strengths and forms of Piperacillin and Tazobactam
Clinical summary
Piperacillin and Tazobactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of intra-abdominal infections in adult and pediatric patients 2 months of age and older. MedsAcross supplies Piperacillin and Tazobactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Piperacillin and TazobactamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zosyn prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Piperacillin and Tazobactam 2 g/250 mg per 50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.